Business
Why the Incannex Healthcare (ASX:IHL) share price is up 15% today
The Incannex Healthcare Limited (ASX: IHL) share price has hit a 5-year high at 29 cents during early trade. The shares have since retreated back to 26 cents, up 18%.
All the excitement comes after the company released an announcement this morning pertaining to an ongoing research program.
Positive results prompting further research
Incannex Healthcare is a pharmaceutical development company utilising medicinal cannabis and psychedelics to generate treatments for a range of disorders and diseases. In today’s update, Incannex discussed the positive results of using its proprietary anti-inflammatory IHL-675A in treating inflammatory bowel disease (IBD).
The company’s IHL-675A treatment is a combination of cannabidiol ‘CBD’…
-
Noosa News18 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business21 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business18 hours agoDicker Data rides the AI trend to double digit growth
-
Business21 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy